Elevance Health revenue and financials

ELV · NYSE · USD

$400.09Change from previous close: +1.41%Absolute change: +$5.58

Close · October 6, 2026

In the fiscal year ended December 2025, Elevance Health reported revenue of $199.13B (+12.49% year over year). Net income was $5.66B, a net margin of 2.8%.

Annual revenue · 2025: $199.13B
  1. $84.86B2016
  2. $90.04B2017
  3. $92.11B2018
  4. $104.21B2019
  5. $121.87B2020
  6. $138.64B2021
  7. $156.6B2022
  8. $171.34B2023
  9. $177.01B2024
  10. $199.13B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+12.49%
2025 vs 2024
Net income growth
−5.32%
2025 vs 2024
Net margin
2.8%
2024: 3.4%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Cash flow · Quarterly
ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Operating cash flow1,9134,33284.01,1352,0541,0177062,6774471,978-2,9712,613
Depreciation and amortization366354-397387380373-336329335331-261426
Capital expenditure-287-235-293-360-267———————
Investing cash flow159-1,642464-1,224-687103-1,638-401-818-2,310-1,029-687
Financing cash flow-1,494-2,515236243-308-1,9091,408-91566832.0-394-994
Dividends paid-373-376-377-381-385-386-373-378-378-379-346-348
Share repurchases-234-1,124-471-876-378———————
Debt issued-70.01,0371,5573,5402618365,03748.01,3381,562339—
Debt repaid-854-2,052-542-2,070110———————
Effect of exchange rates-3.0-9.0-6.0-1.01.01.0-8.07.0-5.0—1.0-4.0
Net change in cash5751667781531,060-7884221,369271-300-4,393928
Free cash flow1,6264,097-2097751,7878213842,3451241,699-3,2972,294
Levered free cash flow1,3572,3291,653-1,2721,4241,4303,7865,678-3,198838-4,3391,865